1.49
前日終値:
$1.47
開ける:
$1.46
24時間の取引高:
76,909
Relative Volume:
0.34
時価総額:
$3.00M
収益:
-
当期純損益:
$-9.34M
株価収益率:
-0.2087
EPS:
-7.14
ネットキャッシュフロー:
$-6.69M
1週間 パフォーマンス:
+2.76%
1か月 パフォーマンス:
+15.50%
6か月 パフォーマンス:
-58.26%
1年 パフォーマンス:
-83.75%
Painreform Ltd Stock (PRFX) Company Profile
PRFX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PRFX
Painreform Ltd
|
1.49 | 2.96M | 0 | -9.34M | -6.69M | -7.14 |
![]()
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
Painreform Ltd (PRFX) 最新ニュース
What makes PainReform Ltd. stock attractive to long term investorsFree Stock Market Return Analysis - jammulinksnews.com
Why PainReform Ltd. stock attracts strong analyst attentionTechnical Breakout List - Newser
What analysts say about PainReform Ltd. stock outlookUnmatched profit growth - jammulinksnews.com
Painreform Shares Drop 11% After Revealing Strategic Stake in LayerBio - MSN
What drives PainReform Ltd. stock priceExceptional profit potential - Autocar Professional
What analysts say about PainReform Ltd. stockUnprecedented growth rates - Autocar Professional
Is PainReform Ltd. a good long term investmentUnmatched market performance - Autocar Professional
PainReform Ltd. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com
Is PainReform Ltd. stock overhyped or has real potentialFree Day Trading Recommendations - Newser
What makes PainReform Ltd. stock price move sharplyWealth Building Stock Portfolio - Newser
How PainReform Ltd. stock performs during market volatilityFree Popular Stock Recommendations - Newser
PainReform (NASDAQ:PRFX) Trading Up 0.7% – Here’s Why - Defense World
PainReform Ltd. enters into a Strategic Investment - GlobeNewswire
LayerBio, Inc. announced that it expects to receive $3 million in funding from PainReform Ltd. - MarketScreener
LayerBio, Inc. announced that it expects to receive $2.95 million in funding from PainReform Ltd. - MarketScreener
Painreform stock falls after announcing strategic investment in LayerBio By Investing.com - Investing.com Australia
PainReform invests in LayerBio to expand into ophthalmology By Investing.com - Investing.com South Africa
PainReform Expands into Ophthalmology with Strategic Investment in LayerBio - TipRanks
PRFX SEC FilingsPainreform Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
PainReform Ltd. enters into a Strategic Investment Agreement to - GuruFocus
PainReform Targets 3M Annual Cataract Surgeries with Revolutionary Dropless Pain Treatment - Stock Titan
Blade Ranger: Consideration from PainReform Transaction Continue - GuruFocus
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales | PRFX Stock News - GuruFocus
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales - Yahoo Finance
Blade Ranger Gains Million-Share Stake in PainReform: Software Sales Trigger $2M Zero-Cost Warrant Conversion - Stock Titan
What Lies Ahead For PainReform Ltd (NASDAQ: PRFX) In 2025? - Stocksregister
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Painreform Ltd (PRFX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):